Standout Papers

Development of potent monoclonal antibody auristatin conjugates for cancer therapy 2003 2026 2010 2018 888
  1. Development of potent monoclonal antibody auristatin conjugates for cancer therapy (2003)
    Svetlana O. Doronina, Brian E. Toki et al. Nature Biotechnology
  2. cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity (2003)
    Joseph A. Francisco, Charles G. Cerveny et al. Blood

Immediate Impact

9 by Nobel laureates 25 from Science/Nature 78 standout
Sub-graph 1 of 18

Citing Papers

Cancer therapy with antibodies
2024 Standout
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
2022 Standout
9 intermediate papers

Works of Clay B. Siegall being referenced

Development of potent monoclonal antibody auristatin conjugates for cancer therapy
2003 Standout
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
2003 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Clay B. Siegall 1227 1426 674 1442 60 3.3k
Victor S. Goldmacher 1553 2081 597 2410 90 6.5k
Pina M. Cardarelli 1086 751 239 1076 64 2.8k
Klára Tótpál 2115 1460 271 1648 57 5.2k
Uwe Zangemeister‐Wittke 1033 861 381 1600 108 5.5k
Wijnand Helfrich 1343 993 191 1172 114 3.6k
Dana F. Chace 542 1814 257 1877 22 3.1k
Pamela A. Trail 467 1187 171 1458 61 3.6k
Leslie A. Khawli 978 1943 198 1059 89 3.4k
Marina Fabbi 3463 928 144 1470 91 5.2k
Kazuyasu Nakamura 1195 1760 230 524 41 3.0k

All Works

Loading papers...

Rankless by CCL
2026